EllenRx®Neurology

Ocrevus denied by insurance? What insurers ask for and how to appeal

ocrelizumab · Sources reviewed Nov 10, 2026 · Sources below

Used for
MS
How it's given
IV infusion
Prior authorization usually required?
Varies by plan

What does my insurer usually ask for before approving Ocrevus?

  • Confirmed MS of a type Ocrevus treatsPlans cover Ocrevus for relapsing MS or primary progressive MS, so your records should show which type you have.
  • Not taking another MS drug at the same timePlans will not pay for Ocrevus together with another long-term MS treatment.
  • Prescribed by or with a neurologistPlans want a neurologist or MS specialist to prescribe it or sign off on it.
  • Hepatitis B blood test before startingThe FDA label says everyone must be tested for hepatitis B before the first dose.
  • Liver and antibody blood tests before startingThe FDA label says to check liver tests and antibody (immunoglobulin) levels before the first dose.
  • For renewals: notes showing MS is stable or betterTo keep coverage, your doctor must show the drug is working for you.

Typical first approval: Up to 1 year (12 months)

Based on published policies from several large commercial insurers and the FDA label (see Sources). Medicare, Medicaid and other plans may use different rules. Your plan's rules may differ.

Why was Ocrevus denied, and what can I do?

  1. Decode your denial letter: Ellen explains the reason in plain words.
  2. Check your denial type and your rights (Medicare or Medicaid if that's your coverage).
  3. Build your appeal, with the step-by-step appeal guide.
Decode my Ocrevus denial

How can I lower the cost of Ocrevus?

If you have Medicare or Medicaid, check each program's terms before you apply.

How does Ocrevus compare?

Safety information

From FDA-approved prescribing information for Ocrevus (Anti-CD20 Monoclonal Antibody).

Boxed warning

Hepatitis B virus reactivation, progressive multifocal leukoencephalopathy (PML)

Do not use if

  • Active hepatitis B virus infection
  • History of life-threatening infusion reaction to ocrelizumab

Key warnings

  • Screen for hepatitis B before starting
  • Infusion reactions common: premedicate with corticosteroid + antihistamine
  • May increase risk of malignancies including breast cancer
  • Vaccinate at least 6 weeks before starting (live vaccines contraindicated during treatment)

This is not a complete list. See the full Ocrevus prescribing information or ask your pharmacist for complete safety information.

Questions about Ocrevus coverage

Does Ocrevus require step therapy?

The insurer policies we checked do not require trying another MS drug first. Your plan may differ.

Why was my Ocrevus denied?

Common denial reasons include: prescription not from a neurologist, concurrent use with another MS disease-modifying therapy, or missing documentation for continuation (disease stability must be demonstrated).

Is the subcutaneous Ocrevus Zunovo covered?

Ocrevus Zunovo (SC formulation) is newer and coverage varies. If you prefer the SC version, your neurologist may need to document why (e.g., poor IV access, infusion reaction history).

For clinicians: Ocrevus prior authorization card (printable).

Sources: FDA prescribing information for Ocrevus (DailyMed) and these insurers' published policies: Aetna (Last Review 10/14/2026), Cigna (Effective Date 08/15/2026), UnitedHealthcare (Effective Date January 1, 2026). Checked 2026-11-10. Sources reviewed Nov 10, 2026.

Not medical advice. This page is for educational and informational purposes only. It does not replace professional medical judgment. Always consult your prescribing physician or pharmacist before starting, stopping, or changing any medication. Ellen does not provide medical advice, diagnose conditions, or recommend treatments. Coverage rules vary by plan and change often; confirm with your plan's current policy.